PURPOSE To assess the impact of pre-procedural evaluation of patients with symptomatic uterine fibroids and adenomyosis in interventional radiology (IR) clinic. METHOD In this IRB-approved, HIPAA-compliant retrospective study, consecutive patients evaluated in the IR clinic in a tertiary academic hospital between 1/1/2015 and 9/30/2018 by a single board-certified interventional radiologist were included. Medical records were reviewed to obtain medical history, imaging and endometrial biopsies results. Impact of IR clinic assessment of clinical, imaging, and pathological findings on patient's clinical course was assessed. Descriptive statistics were used. RESULTS 208 consecutive patients were evaluated in clinic for uterine fibroids 176/208 (85%), adenomyosis 8/208 (4%) or both 24/208 (11%) with age of 44.4 ± 5.8 years and BMI of 30.1 ± 8.6 kg/m2. Leading presenting symptom was menorrhagia in 172/208 (80%) patients, pelvic pain in 91/208 (44%), and urinary symptoms in 88/208 (42%) patients. 159/208 (76%) patients underwent UAE, 12/208 (6%) patients underwent surgery, and 37/208 (18%) patients chose conservative management. 189/208 (91%) patients had pelvic MRI that altered management course in 7/189 (4%) patients due to intracavitary fibroids in two patients, endometrial polyps in two patients, non-enhancing fibroids in two patients, and adnexal mass in one patient. 166/208 (80%) underwent endometrial biopsy that altered management course in one patient (0.6%) due to endometrial intraepithelial neoplasia. CONCLUSION Endometrial biopsy and pelvic MRI are helpful to detect cases of non-enhancing fibroids, intracavitary fibroids, and ovarian and endometrial malignancies and thus altered management of five percent of patients with symptomatic fibroids and adenomyosis.

中文翻译：

---

子宫动脉栓塞术前介入放射科门诊评估的影响：管理上的变化。

目的在介入放射学（IR）诊所评估有症状子宫肌瘤和子宫腺肌病患者的术前评估的影响。方法在这项IRB批准的，符合HIPAA要求的回顾性研究中，纳入了2015年1月1日至2018年9月30日之间在三级学术医院的IR诊所中由单板经认证的介入放射科医生评估的连续患者。审查病历以获得病史，影像学和子宫内膜活检结果。评估了IR临床评估的临床，影像学和病理学发现对患者临床病程的影响。使用描述性统计。结果在临床中对208名连续患者进行了子宫肌瘤176/208（85％），子宫腺肌病8/208（4％）或两者均24/208（11％）的评估，年龄为44.4±5.8岁，BMI为30.1±8。6公斤/平方米。主要的症状是月经过多（172/208例，占80％），骨盆痛（91/208例，占44％）和泌尿系统症状（88/208例，占42％）。159/208（76％）患者接受了阿联酋，12/208（6％）患者接受了手术，而37/208（18％）患者接受了保守治疗。189/208（91％）的患者接受了盆腔MRI检查，由于2例患者的腔内肌瘤，2例患者的子宫内膜息肉，2例患者的非增强型肌瘤和2例附件质量改变了7/189（4％）的患者的治疗过程一位病人。166/208（80％）进行了子宫内膜活检，由于子宫内膜上皮内瘤变改变了一名患者（0.6％）的治疗过程。结论子宫内膜活检和骨盆MRI有助于发现非增强型肌瘤，腔内肌瘤，